Related references
Note: Only part of the references are listed.TAFRO syndrome successfully treated with tocilizumab: A case report and systematic review
Kazuya Sakai et al.
MODERN RHEUMATOLOGY (2018)
Short-term application of tocilizumab during myocardial infarction (STAT-MI)
Matthew B. Carroll et al.
RHEUMATOLOGY INTERNATIONAL (2018)
Acute Myocardial Infarction
Jeffrey L. Anderson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Successful treatment by tocilizumab without steroid in a very severe case of TAFRO syndrome
Tamami Fujiki et al.
CEN CASE REPORTS (2017)
Multicentric Castleman's disease associated with IgA vasculitis (Henoch-Schonlein purpura) responding well to tocilizumab: a case report
Yoichi Oshima et al.
CLINICAL RHEUMATOLOGY (2017)
Effect of a single dose of the interleukin-6 receptor antagonist tocilizumab on inflammation and troponin T release in patients with non-STelevation myocardial infarction: a double-blind, randomized, placebo-controlled phase 2 trial+
Ola Kleveland et al.
EUROPEAN HEART JOURNAL (2016)
Circulating Levels of IL-6 Receptor and gp 130 and Long-Term Clinical Outcomes in ST-Elevation Myocardial Infarction
Vibeke N. Ritschel et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2016)
Inhibition of Interleukin-6 Receptor in a Murine Model of Myocardial Ischemia-Reperfusion
Minke H. T. Hartman et al.
PLOS ONE (2016)
Discovery of innovative therapies for rare immune-Mediated inflammatory Diseases via Off-Label Prescription of Biologics: The Case of IL-6 Receptor Blockade in Castleman's Disease
Anne Musters et al.
FRONTIERS IN IMMUNOLOGY (2015)
Short-term efficacy of the IL6 receptor antibody tocilizumab in patients with HIV-associated multicentric Castleman disease: report of two cases
Azusa Nagao et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2014)
2014 AHA/ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary Syndromes A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
Ezra A. Amsterdam et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Inflammatory Biomarkers, Death, and Recurrent Nonfatal Coronary Events After an Acute Coronary Syndrome in the MIRACL Study
Payman Zamani et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2013)
The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis
Daniel I. Swerdlow et al.
LANCET (2012)
Interleucina 6 y proteína C reactiva ultrasensible para la predicción de la evolución clínica en síndromes coronarios agudos sin elevación del segmento ST
Ángel López-Cuenca et al.
REVISTA ESPANOLA DE CARDIOLOGIA (2012)
Peri-procedural myocardial injury during percutaneous coronary intervention: an important target for cardioprotection
Girish Ganesha Babu et al.
EUROPEAN HEART JOURNAL (2011)
Interleukin-6 and acute coronary syndrome
U Ikeda et al.
CLINICAL CARDIOLOGY (2001)
Share Paper
